Watch DTIL. Know when insiders buy.
One email the day a filing lands. Free.
DTIL
PRECISION BIOSCIENCES INC
6.41
−0.23 −3.46%
USD · close Oct 26
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
57
WATCH · insiders 76, shorts 38
Insiders, 90 days
+$30K
net buying · 3 buys, 0 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $176.9MP/E —DIV YIELD —FCF YIELD -29.35%REV TTM $45.1M +3473.0%NET INCOME −$52.7MNET CASH $63.8M52W 3.57 – 9.28SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q 2027 · Jun 30 | $0 | −100.0% | — | −$19.2M | −$32.7M | — | -1.26 | −$13.4M | $0 | −$13.4M | Aug 6 |
| Q3 2026 · Mar 31 | $10.8M | +37272.4% | — | −$9.1M | −$18.4M | — | -0.75 | −$11.9M | $18K | −$12M | Aug 6 |
| Q2 2026 · Dec 31derived | $34.2M | +5261.1% | — | $12.5M | $20.1M | — | 2.58 | −$11.3M | $19K | −$11.3M | Mar 12 |
| Q1 2026 · Sep 30 | $13K | −97.7% | — | −$20.7M | −$21.8M | — | -1.84 | −$15.3M | $0 | −$15.3M | Nov 3 |
| Q 2026 · Jun 30 | $18K | −100.0% | — | −$21.9M | −$23.5M | −171.8% | -2.13 | −$20.3M | $2K | −$20.3M | Aug 6 |
| Q3 2025 · Mar 31 | $29K | −99.8% | — | −$22.1M | −$20.6M | −339.5% | -2.21 | −$19.1M | $64K | −$19.1M | Aug 6 |
| Q2 2025 · Dec 31derived | $638K | −90.9% | — | −$24.8M | −$17.7M | — | -2.74 | −$18.7M | $97K | −$18.8M | Mar 12 |
| Q1 2025 · Sep 30 | $576K | −95.6% | — | −$21.3M | −$16.4M | — | -2.25 | −$5.9M | $39K | −$6M | Nov 3 |
| Q 2025 · Jun 30 | $49.9M | — | — | $24.1M | $32.7M | — | 4.67 | −$14.9M | $28K | −$14.9M | Nov 3 |
| Q3 2024 · Mar 31 | $17.6M | — | — | −$4.2M | $8.6M | — | 1.70 | −$19M | $86K | −$19.1M | Nov 3 |
| Q2 2024 · Dec 31derived | $7M | — | — | −$14.9M | −$16.3M | — | -4.06 | −$8.4M | −$26K | −$8.4M | Mar 26 |
| Q1 2024 · Sep 30 | $13.1M | — | — | −$12.4M | −$8.1M | — | -2.10 | −$23.1M | $386K | −$23.5M | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Dec 31 | $34.3M | — | −$52.1M | −$45.7M | -133.4% | -3.56 | −$65.8M | $85K | −$65.9M | — | — |
| FY2025 · to Dec 31 | $68.7M | — | −$26.2M | $7.2M | 10.4% | 1.04 | −$58.4M | $250K | −$58.7M | — | — |
| FY2024 · to Dec 31 | $48.7M | — | −$43.7M | −$61.3M | -125.8% | -15.96 | −$84.1M | $2M | −$86.1M | — | — |
| FY2023 · to Dec 31 | $25.1M | — | −$62.3M | −$111.6M | -444.8% | -38.10 | −$45.8M | $3.3M | −$49.1M | — | — |
| FY2022 · to Dec 31 | $115.5M | — | −$39.4M | −$30.6M | -26.5% | -0.52 | −$10.9M | $5.1M | −$15.9M | — | — |
| FY2021 · to Dec 31 | $24.3M | — | −$109.8M | −$109M | -448.9% | -2.09 | −$87.4M | $5M | −$92.4M | — | — |
Every number comes from PRECISION BIOSCIENCES INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.